Sarepta Leapfrogs Pfizer In The US, Launching DMD Gene Therapy Pivotal Trial
The company has initiated the first pivotal double-blind gene therapy trial in DMD in the US in a tight race with Pfizer.
The company has initiated the first pivotal double-blind gene therapy trial in DMD in the US in a tight race with Pfizer.